Video

Education and support enhance care for rare-disease patients


 

REPORTING FROM NORD SUMMIT 2018

– Physicians in primary and specialty care can provide guidance and support to patients with rare diseases by educating themselves about the resources available, according to Tim Boyd, director of state policy for the National Organization for Rare Disorders (NORD).

In an interview at the NORD Rare Summit, held by the National Organization for Rare Disorders, Mr. Boyd and Melinda Burnworth, PharmD, a pharmacist and NORD state volunteer from Arizona, discussed challenges faced by patients with rare diseases, including securing a correct diagnosis, accessing medication, and managing treatment going forward.

Physicians who understand some of the barriers to medication access can help advocate for their patients, explained Mr. Boyd, and those who know about resources for rare disorders can help make a diagnosis.

“All health care providers have an opportunity to enhance care for patients with rare disorders,” said Dr. Burnworth, author of the Rare Disease eResource Guide, available through the American Society of Health-System Pharmacists. Visit rarediseases.org for more information about NORD’s ongoing research and advocacy efforts.

Mr. Boyd and Dr. Burnworth had no financial conflicts to disclose.

Recommended Reading

Bertilimumab granted orphan drug status for bullous pemphigoid
MDedge Dermatology
Angioimmunoblastic T-Cell Lymphoma Mimicking Diffuse Large B-Cell Lymphoma
MDedge Dermatology
Concurrent Notalgia Paresthetica and Brachioradial Pruritus Associated With Cervical Degenerative Disc Disease
MDedge Dermatology
A Rare Case of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
MDedge Dermatology
Certain skin conditions signal potential overgrowth disorder
MDedge Dermatology
Sprain an ankle, get an opioid
MDedge Dermatology
IgA vasculitis may be more common in adults than assumed
MDedge Dermatology
Adult-Onset Still Disease: Persistent Pruritic Papular Rash With Unique Histopathologic Findings
MDedge Dermatology
Trichodysplasia Spinulosa in the Setting of Colon Cancer
MDedge Dermatology
Serlopitant quells prurigo nodularis in phase 2 study
MDedge Dermatology